Transcriptomics Brings New Era of Toxicology Prediction
Read our Nature article on how transcriptomics with machine learning and AI is transforming toxicology…
WHAT’S NEW
Article: Biomanufacturing Without the Big Bioreactors
Learn about J.POD®, our new cGMP manufacturing facility for biologics.
Webinar: Comprehensive and integrated formulation drug development
Our early formulation experts will take you through how having an integrated formulation strategy from…
Webinar: 5 challenging cases for Evotec’s early formulation experts
Ready to solve your bioavailability challenges? Watch our webinar to learn more from our formulation…
Read our Nature Publication on Eliapixant, a Selective P2X3 Receptor Antagonist
Learn about our latest research on a selective P2X3 receptor antagonist for the treatment of…
WELCOME TO OUR COMMUNITY
Want updates about our latest scientific research, news and insights from Evotec, Cyprotex, and Just – Evotec Biologics? Join our Community to receive new content as it is released on the Science Pool.
Latest Blogs
Latest News
Evotec SE reports results for the first half-year 2022 and provides corporate updates
- August 10, 2022
Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN 303
- August 9, 2022